Literature DB >> 6369288

Pre-operative mediastinal evaluation in primary bronchial carcinoma--a review of staging investigations.

J A Elliott.   

Abstract

A review of staging investigations in the preoperative evaluation of mediastinal involvement in primary bronchial carcinoma is presented. The following conclusions are offered as guidelines for the use of mediastinal staging procedures in clinical practice: Surgical staging methods have the over-riding advantage of superior specificity over indirect imaging techniques. Where 67Ga-imaging or CT scanning are not available, routine pre-operative mediastinoscopy or, when appropriate, mediastinotomy will identify most patients with non-resectable disease but this approach entails a high proportion of true negative examinations. Radioisotope ventilation and perfusion lung imaging has no place in the pre-operative staging of lung cancer. Where the techniques are available, 67Ga-imaging and CT scanning have a use in selecting patients for mediastinal exploration. A negative mediastinal 67Ga scan or a negative CT examination suggest that mediastinal exploration will be unrewarding in the vast majority of cases and may be omitted prior to thoracotomy. A positive mediastinal 67Ga scan or the demonstration of abnormal mediastinal nodes by CT is an indication for mediastinal exploration which, if negative should be followed by thoracotomy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6369288      PMCID: PMC2417726          DOI: 10.1136/pgmj.60.700.83

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  76 in total

1.  Bronchogenic carcinoma: cell type and other factors relating to prognosis.

Authors:  J W KIRKLIN; J R McDONALD; O T CLAGETT; H J MOERSCH; R P GAGE
Journal:  Surg Gynecol Obstet       Date:  1955-04

2.  Suprasternal node biopsy in lymphspreading intrathoracic disease.

Authors:  S RADNER
Journal:  Acta Med Scand       Date:  1955-11-30

3.  Relationship of cell type and lymph node metastasis to survival after resection of bronchial carcinoma.

Authors:  T W Shields; J Yee; J H Conn; C D Robinette
Journal:  Ann Thorac Surg       Date:  1975-11       Impact factor: 4.330

4.  Positive mediastinoscopy. An ominous finding.

Authors:  R G Fosburg; M J O'Sullivan; P Ah-Tye; J A Gibbons; J H Oury
Journal:  Ann Thorac Surg       Date:  1974-10       Impact factor: 4.330

5.  Pulmonary and mediastinal lymphography.

Authors:  S Sone; H Tachiri; O Ishida; Y Taji; H Uchida
Journal:  Radiology       Date:  1968-04       Impact factor: 11.105

6.  Preoperative tomographic assessment of the mediastinum in bronchial carcinoma.

Authors:  P K Peace; J L Price
Journal:  Thorax       Date:  1973-05       Impact factor: 9.139

7.  An evaluation of mediastinoscopy in the management of presumably operable bronchial carcinoma.

Authors:  F G Pearson
Journal:  J Thorac Cardiovasc Surg       Date:  1968-05       Impact factor: 5.209

8.  Cobalt-labeled bleomycin--a new radiopharmaceutical for tumor localization. A comparative clinical evaluation with gallium citrate.

Authors:  K P Poulose; A E Watkins; R C Reba; W C Eckelman; M Goodyear
Journal:  J Nucl Med       Date:  1975-09       Impact factor: 10.057

Review 9.  Tumor detection with 67Ga-citrate: a literature survey (1970--1978).

Authors:  C D Teates; S T Bray; B R Williamson
Journal:  Clin Nucl Med       Date:  1978-12       Impact factor: 7.794

10.  Cobalt-57-bleomycin scanning of hila and mediastinum in patients with bronchial carcinoma: a prospective study.

Authors:  J J Rasker; H Beekhuis; A M van de Wal; J N Homan van der Heide; M G Woldring
Journal:  Thorax       Date:  1976-12       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.